
Dalbavancin/Oritavancin for treatment of PJI Part 3
In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Tho...
20 Jan 22min

Dalbavancin/Oritavancin for treatment of PJI Part 2
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they continue the in-depth discussion on long-lasting antibiotics with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, ...
6 Jan 22min

Dalbavancin/Oritavancin for Treatment of PJI Part 1
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an in-depth discussion about long-lasting antibiotics with Vance Fowler, MD, MHS, Thomas Holland, MD, and Thomas Lodise, Phar...
16 Dec 202525min

The Psychosocial Impact of Orthopedic Joint Infections
In this follow-up conversation from the International Consensus Meeting on Infection, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Allison Lastinger, MD, FACP, and Ran Schwarzkopf...
2 Dec 202534min

Spinal Implant Infections Part 2
Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the discussion on spinal implant infections with Geno Tai, MD, and Francis Lovecchio, MD. Thanks to Osteal Therapeutics for sponsoring ...
18 Nov 202534min

Spinal Implant Infections Part 1
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss spinal implant infections with Gino Tai, MD, and Francis Lovecchio, MD in part 1 of this 2 part series. Thanks to Osteal Th...
4 Nov 202534min

Bugged and Baffled: A Case with Angela Hewlett and Curtis Hartman
Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Angela Hewlett, MD, and Curtis...
22 Okt 202535min

Innovative Approaches to Bone and Joint Infections Part 3
Host Jessica Seidelman, MD and guests Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. conclude this 3-part series with discussions on pipeline innovations and adjunctive st...
7 Okt 202530min


















